Global Human Papillomavirus (HPV) Testing Supply, Demand and Key Producers, 2023-2029

Page: 125

Published Date: 11 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

HPV infectionscaninfect thegenitalareasof menincludingtheskinonandaroundthepenisoranus. Theseinfectionscanalso bespreadto themoutHandthethroat. EvenwhenHPV infectionsarepersistent to themalepopulationandcancauseseverediseasessucHasgenitalwarts, analcancers, penilecancers, andcancersof theoropharynx, thereiscurrentlyno HPV test recommendformen. Theapprovedtestsavailableinthemarket areforscreeningwomenforcervicalcancers. Theyarenot usefulforthescreeningof HPV-relatedcancersorgenitalwartsinmen.

This report studies the global Human Papillomavirus (HPV) Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Papillomavirus (HPV) Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Papillomavirus (HPV) Testing that contribute to its increasing demand across many markets.

The global Human Papillomavirus (HPV) Testing market size is expected to reach $ 1110.5 million by 2029, rising at a market growth of 5.2% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Human Papillomavirus (HPV) Testing total market, 2018-2029, (USD Million)
Global Human Papillomavirus (HPV) Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Papillomavirus (HPV) Testing total market, key domestic companies and share, (USD Million)
Global Human Papillomavirus (HPV) Testing revenue by player and market share 2018-2023, (USD Million)
Global Human Papillomavirus (HPV) Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Papillomavirus (HPV) Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Human Papillomavirus (HPV) Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Agilent Technologies, Becton, DickinsonandCompany, QiagenN.V., Thermo FisherScientificInc., Abbott Laboratories, HologicInc., CepheidInc. and SeegeneInc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Papillomavirus (HPV) Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Papillomavirus (HPV) Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Human Papillomavirus (HPV) Testing Market, Segmentation by Type
Pap Smear Test
HPV DNA Test

Global Human Papillomavirus (HPV) Testing Market, Segmentation by Application
Diagnostic Centers
Hospitals
Clinic

Companies Profiled:
Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics

Key Questions Answered
1. How big is the global Human Papillomavirus (HPV) Testing market?
2. What is the demand of the global Human Papillomavirus (HPV) Testing market?
3. What is the year over year growth of the global Human Papillomavirus (HPV) Testing market?
4. What is the total value of the global Human Papillomavirus (HPV) Testing market?
5. Who are the major players in the global Human Papillomavirus (HPV) Testing market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Human Papillomavirus (HPV) Testing Introduction
    1.2 World Human Papillomavirus (HPV) Testing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Human Papillomavirus (HPV) Testing Total Market by Region (by Headquarter Location)
        1.3.1 World Human Papillomavirus (HPV) Testing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Human Papillomavirus (HPV) Testing Market Size (2018-2029)
        1.3.3 China Human Papillomavirus (HPV) Testing Market Size (2018-2029)
        1.3.4 Europe Human Papillomavirus (HPV) Testing Market Size (2018-2029)
        1.3.5 Japan Human Papillomavirus (HPV) Testing Market Size (2018-2029)
        1.3.6 South Korea Human Papillomavirus (HPV) Testing Market Size (2018-2029)
        1.3.7 ASEAN Human Papillomavirus (HPV) Testing Market Size (2018-2029)
        1.3.8 India Human Papillomavirus (HPV) Testing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Papillomavirus (HPV) Testing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Papillomavirus (HPV) Testing Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.2 World Human Papillomavirus (HPV) Testing Consumption Value by Region
        2.2.1 World Human Papillomavirus (HPV) Testing Consumption Value by Region (2018-2023)
        2.2.2 World Human Papillomavirus (HPV) Testing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.4 China Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.5 Europe Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.6 Japan Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.7 South Korea Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.8 ASEAN Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)
    2.9 India Human Papillomavirus (HPV) Testing Consumption Value (2018-2029)

3 World Human Papillomavirus (HPV) Testing Companies Competitive Analysis
    3.1 World Human Papillomavirus (HPV) Testing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Human Papillomavirus (HPV) Testing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Human Papillomavirus (HPV) Testing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Human Papillomavirus (HPV) Testing in 2022
    3.3 Human Papillomavirus (HPV) Testing Company Evaluation Quadrant
    3.4 Human Papillomavirus (HPV) Testing Market: Overall Company Footprint Analysis
        3.4.1 Human Papillomavirus (HPV) Testing Market: Region Footprint
        3.4.2 Human Papillomavirus (HPV) Testing Market: Company Product Type Footprint
        3.4.3 Human Papillomavirus (HPV) Testing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Human Papillomavirus (HPV) Testing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Human Papillomavirus (HPV) Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Human Papillomavirus (HPV) Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Human Papillomavirus (HPV) Testing Consumption Value Comparison
        4.2.1 United States VS China: Human Papillomavirus (HPV) Testing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Human Papillomavirus (HPV) Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Human Papillomavirus (HPV) Testing Companies and Market Share, 2018-2023
        4.3.1 United States Based Human Papillomavirus (HPV) Testing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Human Papillomavirus (HPV) Testing Revenue, (2018-2023)
    4.4 China Based Companies Human Papillomavirus (HPV) Testing Revenue and Market Share, 2018-2023
        4.4.1 China Based Human Papillomavirus (HPV) Testing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Human Papillomavirus (HPV) Testing Revenue, (2018-2023)
    4.5 Rest of World Based Human Papillomavirus (HPV) Testing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Human Papillomavirus (HPV) Testing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Human Papillomavirus (HPV) Testing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Human Papillomavirus (HPV) Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Pap Smear Test
        5.2.2 HPV DNA Test
    5.3 Market Segment by Type
        5.3.1 World Human Papillomavirus (HPV) Testing Market Size by Type (2018-2023)
        5.3.2 World Human Papillomavirus (HPV) Testing Market Size by Type (2024-2029)
        5.3.3 World Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Human Papillomavirus (HPV) Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Diagnostic Centers
        6.2.2 Hospitals
        6.2.3 Clinic
    6.3 Market Segment by Application
        6.3.1 World Human Papillomavirus (HPV) Testing Market Size by Application (2018-2023)
        6.3.2 World Human Papillomavirus (HPV) Testing Market Size by Application (2024-2029)
        6.3.3 World Human Papillomavirus (HPV) Testing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Human Papillomavirus (HPV) Testing Product and Services
        7.1.4 Roche Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Agilent Technologies
        7.2.1 Agilent Technologies Details
        7.2.2 Agilent Technologies Major Business
        7.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Product and Services
        7.2.4 Agilent Technologies Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Agilent Technologies Recent Developments/Updates
        7.2.6 Agilent Technologies Competitive Strengths & Weaknesses
    7.3 Becton, DickinsonandCompany
        7.3.1 Becton, DickinsonandCompany Details
        7.3.2 Becton, DickinsonandCompany Major Business
        7.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product and Services
        7.3.4 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Becton, DickinsonandCompany Recent Developments/Updates
        7.3.6 Becton, DickinsonandCompany Competitive Strengths & Weaknesses
    7.4 QiagenN.V.
        7.4.1 QiagenN.V. Details
        7.4.2 QiagenN.V. Major Business
        7.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Product and Services
        7.4.4 QiagenN.V. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 QiagenN.V. Recent Developments/Updates
        7.4.6 QiagenN.V. Competitive Strengths & Weaknesses
    7.5 Thermo FisherScientificInc.
        7.5.1 Thermo FisherScientificInc. Details
        7.5.2 Thermo FisherScientificInc. Major Business
        7.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product and Services
        7.5.4 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Thermo FisherScientificInc. Recent Developments/Updates
        7.5.6 Thermo FisherScientificInc. Competitive Strengths & Weaknesses
    7.6 Abbott Laboratories
        7.6.1 Abbott Laboratories Details
        7.6.2 Abbott Laboratories Major Business
        7.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Product and Services
        7.6.4 Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Abbott Laboratories Recent Developments/Updates
        7.6.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.7 HologicInc.
        7.7.1 HologicInc. Details
        7.7.2 HologicInc. Major Business
        7.7.3 HologicInc. Human Papillomavirus (HPV) Testing Product and Services
        7.7.4 HologicInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 HologicInc. Recent Developments/Updates
        7.7.6 HologicInc. Competitive Strengths & Weaknesses
    7.8 CepheidInc.
        7.8.1 CepheidInc. Details
        7.8.2 CepheidInc. Major Business
        7.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Product and Services
        7.8.4 CepheidInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 CepheidInc. Recent Developments/Updates
        7.8.6 CepheidInc. Competitive Strengths & Weaknesses
    7.9 SeegeneInc.
        7.9.1 SeegeneInc. Details
        7.9.2 SeegeneInc. Major Business
        7.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Product and Services
        7.9.4 SeegeneInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 SeegeneInc. Recent Developments/Updates
        7.9.6 SeegeneInc. Competitive Strengths & Weaknesses
    7.10 TakaraBio Inc.
        7.10.1 TakaraBio Inc. Details
        7.10.2 TakaraBio Inc. Major Business
        7.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Product and Services
        7.10.4 TakaraBio Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 TakaraBio Inc. Recent Developments/Updates
        7.10.6 TakaraBio Inc. Competitive Strengths & Weaknesses
    7.11 DaAnGeneof SunYat-SenUniversity
        7.11.1 DaAnGeneof SunYat-SenUniversity Details
        7.11.2 DaAnGeneof SunYat-SenUniversity Major Business
        7.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Product and Services
        7.11.4 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 DaAnGeneof SunYat-SenUniversity Recent Developments/Updates
        7.11.6 DaAnGeneof SunYat-SenUniversity Competitive Strengths & Weaknesses
    7.12 PromegaCorporation
        7.12.1 PromegaCorporation Details
        7.12.2 PromegaCorporation Major Business
        7.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Product and Services
        7.12.4 PromegaCorporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 PromegaCorporation Recent Developments/Updates
        7.12.6 PromegaCorporation Competitive Strengths & Weaknesses
    7.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
        7.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Details
        7.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Major Business
        7.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Product and Services
        7.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Developments/Updates
        7.13.6 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Competitive Strengths & Weaknesses
    7.14 Enzo Biochem Inc.
        7.14.1 Enzo Biochem Inc. Details
        7.14.2 Enzo Biochem Inc. Major Business
        7.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Product and Services
        7.14.4 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Enzo Biochem Inc. Recent Developments/Updates
        7.14.6 Enzo Biochem Inc. Competitive Strengths & Weaknesses
    7.15 NorgenBiotek
        7.15.1 NorgenBiotek Details
        7.15.2 NorgenBiotek Major Business
        7.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Product and Services
        7.15.4 NorgenBiotek Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 NorgenBiotek Recent Developments/Updates
        7.15.6 NorgenBiotek Competitive Strengths & Weaknesses
    7.16 DiagCorBioscienceIncLtd
        7.16.1 DiagCorBioscienceIncLtd Details
        7.16.2 DiagCorBioscienceIncLtd Major Business
        7.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Product and Services
        7.16.4 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 DiagCorBioscienceIncLtd Recent Developments/Updates
        7.16.6 DiagCorBioscienceIncLtd Competitive Strengths & Weaknesses
    7.17 Hybribio Limited
        7.17.1 Hybribio Limited Details
        7.17.2 Hybribio Limited Major Business
        7.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Product and Services
        7.17.4 Hybribio Limited Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Hybribio Limited Recent Developments/Updates
        7.17.6 Hybribio Limited Competitive Strengths & Weaknesses
    7.18 ZytovisionGmbH
        7.18.1 ZytovisionGmbH Details
        7.18.2 ZytovisionGmbH Major Business
        7.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Product and Services
        7.18.4 ZytovisionGmbH Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 ZytovisionGmbH Recent Developments/Updates
        7.18.6 ZytovisionGmbH Competitive Strengths & Weaknesses
    7.19 ArborVitaCorporation
        7.19.1 ArborVitaCorporation Details
        7.19.2 ArborVitaCorporation Major Business
        7.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Product and Services
        7.19.4 ArborVitaCorporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 ArborVitaCorporation Recent Developments/Updates
        7.19.6 ArborVitaCorporation Competitive Strengths & Weaknesses
    7.20 Medical& BiologicalLaboratoriesCo., Ltd
        7.20.1 Medical& BiologicalLaboratoriesCo., Ltd Details
        7.20.2 Medical& BiologicalLaboratoriesCo., Ltd Major Business
        7.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Product and Services
        7.20.4 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Developments/Updates
        7.20.6 Medical& BiologicalLaboratoriesCo., Ltd Competitive Strengths & Weaknesses
    7.21 Fujirebio Diagnostics
        7.21.1 Fujirebio Diagnostics Details
        7.21.2 Fujirebio Diagnostics Major Business
        7.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Product and Services
        7.21.4 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.21.5 Fujirebio Diagnostics Recent Developments/Updates
        7.21.6 Fujirebio Diagnostics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Papillomavirus (HPV) Testing Industry Chain
    8.2 Human Papillomavirus (HPV) Testing Upstream Analysis
    8.3 Human Papillomavirus (HPV) Testing Midstream Analysis
    8.4 Human Papillomavirus (HPV) Testing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Papillomavirus (HPV) Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Human Papillomavirus (HPV) Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Human Papillomavirus (HPV) Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Human Papillomavirus (HPV) Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Human Papillomavirus (HPV) Testing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Human Papillomavirus (HPV) Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Human Papillomavirus (HPV) Testing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Human Papillomavirus (HPV) Testing Players in 2022
    Table 12. World Human Papillomavirus (HPV) Testing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Human Papillomavirus (HPV) Testing Company Evaluation Quadrant
    Table 14. Head Office of Key Human Papillomavirus (HPV) Testing Player
    Table 15. Human Papillomavirus (HPV) Testing Market: Company Product Type Footprint
    Table 16. Human Papillomavirus (HPV) Testing Market: Company Product Application Footprint
    Table 17. Human Papillomavirus (HPV) Testing Mergers & Acquisitions Activity
    Table 18. United States VS China Human Papillomavirus (HPV) Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Human Papillomavirus (HPV) Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Human Papillomavirus (HPV) Testing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Human Papillomavirus (HPV) Testing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Human Papillomavirus (HPV) Testing Revenue Market Share (2018-2023)
    Table 23. China Based Human Papillomavirus (HPV) Testing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Human Papillomavirus (HPV) Testing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Human Papillomavirus (HPV) Testing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Human Papillomavirus (HPV) Testing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Human Papillomavirus (HPV) Testing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Human Papillomavirus (HPV) Testing Revenue Market Share (2018-2023)
    Table 29. World Human Papillomavirus (HPV) Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Human Papillomavirus (HPV) Testing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Human Papillomavirus (HPV) Testing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Human Papillomavirus (HPV) Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Human Papillomavirus (HPV) Testing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Human Papillomavirus (HPV) Testing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Roche Basic Information, Area Served and Competitors
    Table 36. Roche Major Business
    Table 37. Roche Human Papillomavirus (HPV) Testing Product and Services
    Table 38. Roche Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Roche Recent Developments/Updates
    Table 40. Roche Competitive Strengths & Weaknesses
    Table 41. Agilent Technologies Basic Information, Area Served and Competitors
    Table 42. Agilent Technologies Major Business
    Table 43. Agilent Technologies Human Papillomavirus (HPV) Testing Product and Services
    Table 44. Agilent Technologies Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Agilent Technologies Recent Developments/Updates
    Table 46. Agilent Technologies Competitive Strengths & Weaknesses
    Table 47. Becton, DickinsonandCompany Basic Information, Area Served and Competitors
    Table 48. Becton, DickinsonandCompany Major Business
    Table 49. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product and Services
    Table 50. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Becton, DickinsonandCompany Recent Developments/Updates
    Table 52. Becton, DickinsonandCompany Competitive Strengths & Weaknesses
    Table 53. QiagenN.V. Basic Information, Area Served and Competitors
    Table 54. QiagenN.V. Major Business
    Table 55. QiagenN.V. Human Papillomavirus (HPV) Testing Product and Services
    Table 56. QiagenN.V. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. QiagenN.V. Recent Developments/Updates
    Table 58. QiagenN.V. Competitive Strengths & Weaknesses
    Table 59. Thermo FisherScientificInc. Basic Information, Area Served and Competitors
    Table 60. Thermo FisherScientificInc. Major Business
    Table 61. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product and Services
    Table 62. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Thermo FisherScientificInc. Recent Developments/Updates
    Table 64. Thermo FisherScientificInc. Competitive Strengths & Weaknesses
    Table 65. Abbott Laboratories Basic Information, Area Served and Competitors
    Table 66. Abbott Laboratories Major Business
    Table 67. Abbott Laboratories Human Papillomavirus (HPV) Testing Product and Services
    Table 68. Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Abbott Laboratories Recent Developments/Updates
    Table 70. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 71. HologicInc. Basic Information, Area Served and Competitors
    Table 72. HologicInc. Major Business
    Table 73. HologicInc. Human Papillomavirus (HPV) Testing Product and Services
    Table 74. HologicInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. HologicInc. Recent Developments/Updates
    Table 76. HologicInc. Competitive Strengths & Weaknesses
    Table 77. CepheidInc. Basic Information, Area Served and Competitors
    Table 78. CepheidInc. Major Business
    Table 79. CepheidInc. Human Papillomavirus (HPV) Testing Product and Services
    Table 80. CepheidInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. CepheidInc. Recent Developments/Updates
    Table 82. CepheidInc. Competitive Strengths & Weaknesses
    Table 83. SeegeneInc. Basic Information, Area Served and Competitors
    Table 84. SeegeneInc. Major Business
    Table 85. SeegeneInc. Human Papillomavirus (HPV) Testing Product and Services
    Table 86. SeegeneInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. SeegeneInc. Recent Developments/Updates
    Table 88. SeegeneInc. Competitive Strengths & Weaknesses
    Table 89. TakaraBio Inc. Basic Information, Area Served and Competitors
    Table 90. TakaraBio Inc. Major Business
    Table 91. TakaraBio Inc. Human Papillomavirus (HPV) Testing Product and Services
    Table 92. TakaraBio Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. TakaraBio Inc. Recent Developments/Updates
    Table 94. TakaraBio Inc. Competitive Strengths & Weaknesses
    Table 95. DaAnGeneof SunYat-SenUniversity Basic Information, Area Served and Competitors
    Table 96. DaAnGeneof SunYat-SenUniversity Major Business
    Table 97. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Product and Services
    Table 98. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. DaAnGeneof SunYat-SenUniversity Recent Developments/Updates
    Table 100. DaAnGeneof SunYat-SenUniversity Competitive Strengths & Weaknesses
    Table 101. PromegaCorporation Basic Information, Area Served and Competitors
    Table 102. PromegaCorporation Major Business
    Table 103. PromegaCorporation Human Papillomavirus (HPV) Testing Product and Services
    Table 104. PromegaCorporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. PromegaCorporation Recent Developments/Updates
    Table 106. PromegaCorporation Competitive Strengths & Weaknesses
    Table 107. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Basic Information, Area Served and Competitors
    Table 108. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Major Business
    Table 109. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Product and Services
    Table 110. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Developments/Updates
    Table 112. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Competitive Strengths & Weaknesses
    Table 113. Enzo Biochem Inc. Basic Information, Area Served and Competitors
    Table 114. Enzo Biochem Inc. Major Business
    Table 115. Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Product and Services
    Table 116. Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Enzo Biochem Inc. Recent Developments/Updates
    Table 118. Enzo Biochem Inc. Competitive Strengths & Weaknesses
    Table 119. NorgenBiotek Basic Information, Area Served and Competitors
    Table 120. NorgenBiotek Major Business
    Table 121. NorgenBiotek Human Papillomavirus (HPV) Testing Product and Services
    Table 122. NorgenBiotek Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. NorgenBiotek Recent Developments/Updates
    Table 124. NorgenBiotek Competitive Strengths & Weaknesses
    Table 125. DiagCorBioscienceIncLtd Basic Information, Area Served and Competitors
    Table 126. DiagCorBioscienceIncLtd Major Business
    Table 127. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Product and Services
    Table 128. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. DiagCorBioscienceIncLtd Recent Developments/Updates
    Table 130. DiagCorBioscienceIncLtd Competitive Strengths & Weaknesses
    Table 131. Hybribio Limited Basic Information, Area Served and Competitors
    Table 132. Hybribio Limited Major Business
    Table 133. Hybribio Limited Human Papillomavirus (HPV) Testing Product and Services
    Table 134. Hybribio Limited Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Hybribio Limited Recent Developments/Updates
    Table 136. Hybribio Limited Competitive Strengths & Weaknesses
    Table 137. ZytovisionGmbH Basic Information, Area Served and Competitors
    Table 138. ZytovisionGmbH Major Business
    Table 139. ZytovisionGmbH Human Papillomavirus (HPV) Testing Product and Services
    Table 140. ZytovisionGmbH Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. ZytovisionGmbH Recent Developments/Updates
    Table 142. ZytovisionGmbH Competitive Strengths & Weaknesses
    Table 143. ArborVitaCorporation Basic Information, Area Served and Competitors
    Table 144. ArborVitaCorporation Major Business
    Table 145. ArborVitaCorporation Human Papillomavirus (HPV) Testing Product and Services
    Table 146. ArborVitaCorporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. ArborVitaCorporation Recent Developments/Updates
    Table 148. ArborVitaCorporation Competitive Strengths & Weaknesses
    Table 149. Medical& BiologicalLaboratoriesCo., Ltd Basic Information, Area Served and Competitors
    Table 150. Medical& BiologicalLaboratoriesCo., Ltd Major Business
    Table 151. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Product and Services
    Table 152. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 153. Medical& BiologicalLaboratoriesCo., Ltd Recent Developments/Updates
    Table 154. Fujirebio Diagnostics Basic Information, Area Served and Competitors
    Table 155. Fujirebio Diagnostics Major Business
    Table 156. Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Product and Services
    Table 157. Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 158. Global Key Players of Human Papillomavirus (HPV) Testing Upstream (Raw Materials)
    Table 159. Human Papillomavirus (HPV) Testing Typical Customers
List of Figure
    Figure 1. Human Papillomavirus (HPV) Testing Picture
    Figure 2. World Human Papillomavirus (HPV) Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Human Papillomavirus (HPV) Testing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Human Papillomavirus (HPV) Testing Revenue (2018-2029) & (USD Million)
    Figure 13. Human Papillomavirus (HPV) Testing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Human Papillomavirus (HPV) Testing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Human Papillomavirus (HPV) Testing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Human Papillomavirus (HPV) Testing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Papillomavirus (HPV) Testing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Papillomavirus (HPV) Testing Markets in 2022
    Figure 27. United States VS China: Human Papillomavirus (HPV) Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Human Papillomavirus (HPV) Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Human Papillomavirus (HPV) Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Human Papillomavirus (HPV) Testing Market Size Market Share by Type in 2022
    Figure 31. Pap Smear Test
    Figure 32. HPV DNA Test
    Figure 33. World Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2018-2029)
    Figure 34. World Human Papillomavirus (HPV) Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Human Papillomavirus (HPV) Testing Market Size Market Share by Application in 2022
    Figure 36. Diagnostic Centers
    Figure 37. Hospitals
    Figure 38. Clinic
    Figure 39. Human Papillomavirus (HPV) Testing Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Human Papillomavirus (HPV) Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Human Papillomavirus (HPV) Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Medical Care

Global Human Papillomavirus (HPV) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Human Papillomavirus (HPV) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Human Papillomavirus (HPV) Testing market size was valued at USD 778.9 million in 2023 and is forecast to a readjusted size of USD 1110.5 million by 2030 with a CAGR of 5.2% during review period.

Product Tags

human papillomavirus hpv testing

Human Papillomavirus (HPV) Testing

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>